BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17656962)

  • 1. Study of serum lipids in leprosy.
    Gupta A; Koranne RV; Kaul N
    Indian J Dermatol Venereol Leprol; 2002; 68(5):262-6. PubMed ID: 17656962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte superoxide dismutase, catalase activities and hydrogen peroxide induced lipid peroxidation in leprosy.
    Prasad CV; Kodliwadmath MV; Kodliwadmath GB
    Lepr Rev; 2007 Dec; 78(4):391-7. PubMed ID: 18309714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients.
    Makonkawkeyoon S; Kasinrerk W; Supajatura V; Hirunpetcharat C; Vithayasai V
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):311-8. PubMed ID: 1695911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte glutathione peroxidase, glutathione reductase activities and blood glutathione content in leprosy.
    Prasad CV; Kodliwadmath MV; Kodliwadmath GB
    J Infect; 2008 Jun; 56(6):469-73. PubMed ID: 18440071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histopathological correlation in the classification of leprosy.
    Bhatia AS; Katoch K; Narayanan RB; Ramu G; Mukherjee A; Lavania RK
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):433-8. PubMed ID: 8228443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of serum lipids and lipoproteins in leprosy.
    Ahaley SK; Sardeshmukh AS; Suryakar AN; Samson PD
    Indian J Lepr; 1992; 64(1):91-8. PubMed ID: 1573306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
    Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1-antitrypsin in leprosy.
    Deshpande SV; Zawar PB; Chawhan RN; Sengupta SR; Mehta MC
    Indian J Lepr; 1985; 57(4):767-72. PubMed ID: 3938987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
    Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
    Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of cultivable mycobacteria from leprosy skin.
    Sharma RK; Katoch K; Sharma VD; Shivannavar CT; Natarajan M; Katoch VM
    Indian J Lepr; 1995; 67(3):321-8. PubMed ID: 8576611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinico-pathological study of lymph node involvement in leprosy.
    Kar HK; Mohanty HC; Mohanty GN; Nayak UP
    Lepr India; 1983 Oct; 55(4):725-38. PubMed ID: 6668933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme immunoassay of phagocytosis stimulating tetrapeptide "tuftsin" in normal and leprosy sera.
    Kaur J; Khare S; Bhutani LK; Rao DN
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):576-81. PubMed ID: 1802940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins.
    Memon RA; Hussain R; Raynes JG; Lateff A; Chiang TJ
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):115-22. PubMed ID: 8690968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulins in leprosy.
    Gupta RM; Gupta SC; Singh G; Khanna S
    Int J Lepr Other Mycobact Dis; 1978; 46(3-4):342-5. PubMed ID: 83308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological examination of skin biopsies from an epidemiological study of leprosy in northern Malawi.
    McDougall AC; Ponnighaus JM; Fine PE
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):88-98. PubMed ID: 3559338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of anti-PGL-1, anti-35 kDa and anti-lipoarabinomannan assays for serodiagnosis of leprosy.
    Jayapal V; Selvibai G; Mahalakshmi K; Pushkala ; Regunath K; Subramanian S
    Indian J Lepr; 2001; 73(3):229-37. PubMed ID: 11840595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinico-pathological study of macular lesions in leprosy.
    Kar PK; Arora PN; Ramasastry CV; Sayal SK; Dhaka RS
    Indian J Lepr; 1994; 66(4):435-42. PubMed ID: 7714352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of clinical and histopathological studies in classification of leprosy.
    Dubey GK; Joglekar VK; Grover S; Chaubey BS
    Lepr India; 1981 Oct; 53(4):562-5. PubMed ID: 7334784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum zinc, copper, magnesium, proteins and superoxide dismutase in leprosy patients on multidrug therapy--a follow-up study.
    Sethi NC; Madadi AJ; Bhandari S
    Indian J Lepr; 1996; 68(4):325-33. PubMed ID: 9001900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.